0001484612-22-000030.txt : 20220404
0001484612-22-000030.hdr.sgml : 20220404
20220404171512
ACCESSION NUMBER: 0001484612-22-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220401
FILED AS OF DATE: 20220404
DATE AS OF CHANGE: 20220404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vazquez Martin
CENTRAL INDEX KEY: 0001823380
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39513
FILM NUMBER: 22803676
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DR.
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outset Medical, Inc.
CENTRAL INDEX KEY: 0001484612
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 200514392
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
BUSINESS PHONE: 669-231-8200
MAIL ADDRESS:
STREET 1: 3052 ORCHARD DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95134
FORMER COMPANY:
FORMER CONFORMED NAME: Home Dialysis Plus, Ltd.
DATE OF NAME CHANGE: 20100219
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-04-01
0
0001484612
Outset Medical, Inc.
OM
0001823380
Vazquez Martin
3052 ORCHARD DRIVE
SAN JOSE
CA
95134
0
1
0
0
Chief Operating Officer
Common Stock
2022-04-01
4
M
0
6668
3.88
A
56163
D
Common Stock
2022-04-01
4
S
0
6668
45.8095
D
49495
D
Common Stock
2022-04-01
4
M
0
6500
3.88
A
55995
D
Common Stock
2022-04-01
4
S
0
6500
45.7398
D
49495
D
Common Stock
2022-04-01
4
M
0
6500
3.88
A
55995
D
Common Stock
2022-04-01
4
S
0
6500
45.7655
D
49495
D
Common Stock
2022-04-01
4
M
0
332
3.88
A
49827
D
Common Stock
2022-04-01
4
S
0
332
45.8095
D
49495
D
Non-Qualified Stock Option (right to buy)
3.88
2022-04-01
4
M
0
332
0.0
D
2027-12-19
Common Stock
332
18743
D
Performance Options (right to buy)
3.88
2022-04-01
4
M
0
6668
0.0
D
2027-12-19
Common Stock
6668
131007
D
Performance Options (right to buy)
3.88
2022-04-01
4
M
0
6500
0.0
D
2027-12-19
Common Stock
6500
124507
D
Performance Options (right to buy)
3.88
2022-04-01
4
M
0
6500
0.0
D
2027-12-19
Common Stock
6500
118007
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $44.00-$44.99 - 200 shares; $45.00-$45.99 - 4,890 shares; $46.00 - $46.99 - 1,910 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $44.00-$44.99 - 100 shares; $45.00-$45.99 - 4,985 shares; $46.00 - $46.99 - 1,415 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 5,012 shares; $46.00 - $46.99 - 1,488 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
This option vests if and to the extent that (i) the sum of (A) the 30-day closing price of one Share and (B) the Aggregate Cash Distributions is equal to or greater than $20.46 (reduced to $19.12 in 2020) on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to one greater than $20.46 (increased to $20.86 in 2020) as of the effective date of such Corporate Event.
By: John L Brottem For: Martin Vazquez
2022-04-04